Raghu Kalluri
![Raghu Kalluri Raghu Kalluri](https://kinase-inhibitors-summit.com/wp-content/uploads/sites/649/2022/11/raghu_kalluri.jpg.resize.810.1150.high_-e1667392980316-150x150.jpg)
Company: University Texas MD Anderson Center
Job title: Professor- Cancer Biology
Seminars:
Targeting Oncogenic KRAS-G12D Mutation Employing Engineered Exosomes in Pancreatic Cancer 11:30 am
Direct inhibitors do not exist for KRAS-G12D We engineered exosomes to deliver siRNA specific to Kras-G12D (iExosomes). The iExosomes target pancreatic cancer cells to suppress tumor growth and increase the overall survival of mice with PDAC Preclinical studies, GLP-toxicology studies, clinical grade GMP production and FDA IND filing led to a Phase I clinical trial…Read more
day: Day Two